ARCH V ENTREPRENEURS FUND LP

CIK 00011617404 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001161740

Recent Transactions

31 trades

Exercise of In-Money
IMPINJ INC$PI
Series 2 Preferred Warrant (Right to Buy)
2016-07-26−32,022→ 0 total
Conversion
IMPINJ INC$PI
Common Stock
2016-07-26+820,935→ 820,935 total
Conversion
IMPINJ INC$PI
Series 2 Preferred Stock
2016-07-26−421,683→ 0 total
Conversion
IMPINJ INC$PI
Series 1 Preferred Stock
2016-07-26−820,935→ 0 total
Tax Payment
IMPINJ INC$PI
Common Stock
2016-07-26$14.00/sh−21,313→ 1,366,735 total
Exercise of In-Money
IMPINJ INC$PI
Common Stock
2016-07-26$7.46/sh+40,025→ 1,388,048 total
Conversion
IMPINJ INC$PI
Common Stock
2016-07-26+820,935→ 820,935 total
Conversion
IMPINJ INC$PI
Common Stock
2016-07-26+527,088→ 1,348,023 total
Exercise of In-Money
IMPINJ INC$PI
Series 2 Preferred Warrant (Right to Buy)
2016-07-26−32,022→ 0 total
Conversion
IMPINJ INC$PI
Series 1 Preferred Stock
2016-07-26−820,935→ 0 total
Exercise of In-Money
IMPINJ INC$PI
Common Stock
2016-07-26$9.32/sh+40,026→ 1,388,049 total
Tax Payment
IMPINJ INC$PI
Common Stock
2016-07-26$14.00/sh−26,641→ 1,361,408 total
Conversion
IMPINJ INC$PI
Series 2 Preferred Stock
2016-07-26−421,684→ 0 total
Conversion
IMPINJ INC$PI
Common Stock
2016-07-26+527,088→ 1,348,023 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Conversion
NeurogesX Inc
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+458,903→ 458,903 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+1,834,421→ 2,061,421 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total
Conversion
NeurogesX Inc
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+11,004→ 11,004 total

Companies

Recent Filings

Address

8755 WEST HIGGINS ROAD SUITE 1025

CHICAGO, IL, 60631

View on SEC.gov